Recurrence: all 3,523 studies

Page 16 of 36. Open to participants first (870), then studies with results posted, then the rest; newest registration first within each.

• A Study to Evaluate the Therapeutic Benefit of Tisagenlecleucel Compared to Existing Standard of Care in German Adult Patients With Relapsed or Refractory Diffuse Large B-cell LymphomaCompletedNCT07103486
• Comparison Between Laser and Open Fistula Surgeries in the Management of Fistula - In - AnoActive, not recruitingNCT07083778Not applicable
• A Comparative Study Between TAPP and Lichtenstein Techniques for Inguinal Hernia SurgeryActive, not recruitingNCT07067281Not applicable
• Microbiome and Colorectal Cancer RecurrenceCompletedNCT07057076
• Effectiveness of Oral Melatonin vs Oral Tranexamic Acid in the Treatment and Recurrence of MelasmaActive, not recruitingNCT07034560Phase 4
• Impact of Perioperative Hyperoxia on Cancer Recurrence and Mortality After Elective Colorectal Cancer SurgeryCompletedNCT06989346
• Early Recurrence of Renal Colic: Predictive FactorsCompletedNCT06982430
• Five-year Recurrence After LCMECompletedNCT06924931
• Short-term Stability of Tooth-borne vs Bone-borne Maxillary Expansion: A Parallel Cohort StudyCompletedNCT06916299Not applicable
• A Study of LCAR-AIO CAR-T Cells for Treating Relapsed/Refractory Neurological Autoimmune DiseasesWithdrawnNCT06869278Phase 1
• A Study of LCAR-AIO in Subjects With Relapsed/Refractory Autoimmune DiseasesWithdrawnNCT06866080Early Phase 1
• Duration of Antibiotic Therapy in Acute Kidney Graft Pyelonephritis (AGPN): Effect on the Risk of RecurrenceActive, not recruitingNCT06848816
• Clinical Trial on 7-day Followed by Maintenance Therapy for 10 Weeks Vs. 14-day and No Maintenance Course of Prednisolone for the Treatment of Infantile Epileptic Spasms Syndrome (IESS)Active, not recruitingNCT06838559Phase 4
• Percutaneous Tumor Ablation Vs Partial Nephrectomy for Small Renal Mass: the Impact of Histologic Variant and Tumor SizeCompletedNCT06829888
• Tazemetostat in Combination With Zanubrutinib and Anti-CD20 Monoclonal Antibody in Relapsed or Refractory B-cell Non-Hodgkin LymphomaActive, not recruitingNCT06824701Phase 1
• Validation of the TRAIN-AI for the Risk of HCC Recurrence After Liver TransplantationCompletedNCT06799468
• Detection Algorithm for Recurrence or Relapse of Depression Thanks to a SmartwachActive, not recruitingNCT06789822Not applicable
• CART123 + Ruxolitinib in Relapsed/Refractory AMLActive, not recruitingNCT06768476Phase 1
• A Phase 1b/2 Study of Intravenous Brincidofovir in Patients With Relapsed or Refractory Lymphoma and Relapsed or Refractory Extranodal Natural Killer/T-cell LymphomaSuspendedNCT06761677Phase 1/2
• A Study of AUR104 in Patients With Relapsed/Refractory Lymphoid Malignancies (VIJAY-1)TerminatedNCT06761586Phase 1
• Study of PF-07220060 With Letrozole in Adults With HR-positive HER2-negative Breast Cancer Who Have Not Received Anticancer Treatment for Advanced/Metastatic DiseaseActive, not recruitingNCT06760637Phase 3
• Native Tissue Repair in Pelvic Organ Prolapse -Long-term Results and Risk of Re-operationCompletedNCT06744972
• Using Gilteritinib to Keep People With Acute Myeloid Leukemia Cancer-free After a Stem Cell TransplantCompletedNCT06734585
• A Study of TLN-254 in Participants With Relapsed or Refractory T-cell LymphomaActive, not recruitingNCT06733441Phase 1
• Ex-vivo Hypotermic Perfusion in Patients with Hepatocellular Carcinoma to Reduce the Incidence of Tumor RecurrenceCompletedNCT06720675
• Recurrence and Predictive OCT Biomarkers in Quiescent Neovascular AMDActive, not recruitingNCT06717139
• BSB-1001 in Patients Undergoing HLA-Matched Allogenic Hematopoietic Stem Cell Transplant for AML, ALL or MDSTerminatedNCT06704152Phase 1/2
• A Study of the TactiFlex SE Catheter and Volt PFA Generator in Subjects With PAF:CompletedNCT06676072Not applicable
• A Study of LCAR-AIO in Subjects With Relapsed/Refractory Systemic Lupus ErythematosusCompletedNCT06653556Early Phase 1
• Association of Ex Vivo Drug Response ( EVDR) and Clinical Outcome in Acute Myeloid Leukaemia (EXCYTE-2)CompletedNCT06648512
• Toripalimab and JS004 Combined With Platinum-based Chemotherapy for Relapsed and Extensive-stage Small Cell Lung CancerCompletedNCT06648200Phase 2
• PEP-CMV + Nivolumab for Newly Diagnosed Diffuse Midline Glioma/High-grade Glioma and Recurrent Diffuse Midline Glioma/High-grade Glioma, Medulloblastoma, and EpendymomaSuspendedNCT06639607Phase 1/2
• CD7 CAR T Cells (RD13-02) in the Treatment of Relapsed/Refractory Severe Aplastic AnemiaSuspendedNCT06622694Phase 1
• A Study of JNJ-87562761 in Participants With Relapsed or Refractory Multiple MyelomaActive, not recruitingNCT06604715Phase 1
• Can Recurrence of Cancer in the Oropharynx be Detected by Blood Samples?Active, not recruitingNCT06592716
• Radical Versus Conservative Surgery in Liver Cystic Echinococcosis: a Prospective Cohort Study in a High-volume Western CentreCompletedNCT06570876
• ONO-4578-06:Phase I Study of ONO-4578 and Letrozole Plus CDK4 /6 Inhibitors in Breast CancerCompletedNCT06570031Phase 1
• A Study to Evaluate S227928 as a Single Agent and in Combination With Venetoclax in Patients With R/R AML, MDS/AML, or CMMLTerminatedNCT06563804Phase 1/2
• A Study to Learn About the Investigational Medicine Called PF-06821497 (Mevrometostat) in Men With mCRPC Who Were Previously Treated With Abiraterone Acetate for Prostate Cancer (MEVPRO-1).Active, not recruitingNCT06551324Phase 3
• Mesentery Guide Identify Microscopic Clean Resection and Reduces Crohn's Endoscopic RecurrenceCompletedNCT06550843
• A Phase I Study to Investigate the Tolerability and Safety of ONO-4685 Given as Monotherapy in T Cell Lymphoma and CLL/SLLActive, not recruitingNCT06547528Phase 1
• Influence of Anaesthesia Type on Multiple Sclerosis RelapseCompletedNCT06526130
• On the Safety, Tolerability, and Efficacy of UTAA09 Injection in the Treatment of LymphomaStatus unknownNCT06503211Phase 1
• Lamivudine for Solid TumorsActive, not recruitingNCT06494579Phase 1/2
• A Phase IIa Clinical Study of Purinostat Mesylate for Injection in Patients With Peripheral T-Cell Lymphoma and Cutaneous T-Cell LymphomaActive, not recruitingNCT06485219Phase 2
• Non Interventional Study to Investigate the Safety and Effectiveness in Patients With Relapsed and Refractory Multiple Myeloma Treated With Elranatamab Under the Actual Use.Active, not recruitingNCT06479954
• Thalidomide Combined With Chemotherapy in the Treatment of Relapsed or Refractory Yolk Sac TumorCompletedNCT06470464Phase 2
• Safety, Tolerability and Efficacy of JCXH-211 in Patients With Recurrent or Progressive High-Grade GliomaWithdrawnNCT06468605Phase 1
• Intra-Tumoral Vascular Growth Patterns is a Robust Indicator of Adjuvant Therapy Following Liver Resection in HCCActive, not recruitingNCT06461936
• Nivolumab Plus Gemcitabine in Patients With Recurrent or Metastatic Nasopharyngeal Carcinoma-HN17-11CompletedNCT06440187Phase 2
• Prevention and Early Detection of Ulcer Recurrence in Patients With Type II Diabetes MellitusCompletedNCT06434922Not applicable
• Efficacy of Dapagliflozin on Recurrence After Catheter Ablation for Atrial FibrillationCompletedNCT06433479Not applicable
• Sustainable and Healthy Return-to-Work Program - PRATICAdr 2.0CompletedNCT06397326Not applicable
• Impact of Hepatectomy on HCC RecurrenceCompletedNCT06390228
• Organ/Space Surgical Site Infection and Recurrence and Survival in Rectal Cancer SurgeryCompletedNCT06382415
• A Study of CLN-619 (Anti-MICA/MICB Antibody) in Patients With Relapsed and Refractory Multiple MyelomaActive, not recruitingNCT06381141Phase 1
• A Study of RO7617991 in Patients With Locally Advanced or Metastatic MAGE-A4-Positive Solid TumorsWithdrawnNCT06372574Phase 1
• Safety, Pharmacokinetics, and Preliminary Efficacy of BYON4413 in Acute Myeloid Leukemia and Myelodysplastic Neoplasms.Active, not recruitingNCT06359002Phase 1
• Systemic Oxidative Stress Score as a Predictor of Gastric Cancer Survival and Recurrence RiskCompletedNCT06337279
• Expanded Access of Imvotamab (IGM-2323) in Patients With R/R NHLNo longer availableNCT06331832
• SENTI-202: Off-the-shelf Logic Gated CAR NK Cell Therapy in Adults With CD33 and/or FLT3 Blood Cancers Including AML/MDSActive, not recruitingNCT06325748Phase 1
• Prognostic Factors Influencing the Recurrence Rate and Survival of Patients With Colorectal Cancer: a Single Institution ExperienceCompletedNCT06325410
• 3-point With 1-point Mesh Fixation in TAPP for Inguinal HerniaCompletedNCT06314152Not applicable
• A Study to Evaluate the Efficacy and Safety of Liso-cel Compared to Standard of Care in Adults With Relapsed or Refractory Follicular LymphomaWithdrawnNCT06313996Phase 3
• Descartes-15 for Patients With Relapsed/Refractory Multiple MyelomaTerminatedNCT06304636Phase 1
• Pemigatinib in Patients With Relapsed or Refractory B-cell Non-Hodgkin LymphomasActive, not recruitingNCT06300528Phase 2
• Targeting CD19/CD20 Dual-targeted Cell in Patients With Relapsed/Refractory B-cell Non-Hodgkin LymphomaTerminatedNCT06295549Phase 1
• Spleen Preserving Surgery for Splenic Hydatidosis: A Cohort Study on Short and Long-Term OutcomesCompletedNCT06289816
• The Diagnostic Accuracy of Advanced Imaging in Identifying Suspected Skin Cancer (Basal Cell Carcinoma) Around the EyesCompletedNCT06279143
• Evaluation of Nitric Oxide Nasal Spray (NONS) for Treatment of Recurrent Acute RhinosinusitisCompletedNCT06264141Phase 2
• The Adjuvant Effect of HPV Vaccination on Recurrence of Cervical Precancer or Carcinoma in Women Undergoing ConizationCompletedNCT06258564
• Study of KTE-X19 in Adult Japanese Participants With Relapsed/Refractory Mantle Cell Lymphoma or Relapsed/Refractory B-precursor Acute Lymphoblastic LeukemiaActive, not recruitingNCT06253663Phase 2
• VETC is an Effective Marker for Postoperative Adjuvant ImmunotherapyCompletedNCT06253364
• ctDNA for Early Detection of Recurrence in MelanomaActive, not recruitingNCT06246227
• AB-2100, an Integrated Circuit T Cell Therapy in Patients With Recurrent Clear-cell Renal Cell Carcinoma (ccRCC)Active, not recruitingNCT06245915Phase 1/2
• Biomarkers of Recurrence and Progression in Non-muscle Invasive Bladder CancerCompletedNCT06235853
• A Study to Evaluate Efficacy and Safety of Alnuctamab Compared to Standard of Care Regimens in Participants With Relapsed or Refractory Multiple Myeloma (RRMM)WithdrawnNCT06232707Phase 3
• Cladribine Venetoclax in Monocytic AMLActive, not recruitingNCT06232655Phase 2
• Efficacy and Safety of Linperlisib in Relapsed/Refractory Large Granular T Lymphocytic LeukemiaCompletedNCT06224257Phase 2
• A Study to Learn About the Effects of the Combination of Elranatamab (PF-06863135) and Iberdomide in Patients With Relapsed or Refractory Multiple Myeloma (MagnetisMM-30)Active, not recruitingNCT06215118Phase 1
• Selinexor, Cyclophosphamide and Prednisone in MyelomaCompletedNCT06212596Phase 2
• CAR-T for Autoimmune Hemolytic Anemia Patients Who Have Failed Three or More Lines of TherapyTerminatedNCT06212154Phase 1
• Dendritic Cell Vaccination to Prevent Hepatocellular Carcinoma Recurrence After Liver Resection - Phase II Clinical TrialActive, not recruitingNCT06193733Phase 2
• Re-Administration of C134 in Patients With Recurrent GBM (C134-HSV-1)TerminatedNCT06193174Phase 1
• Bovine Colostrum for Prophylaxis Against Recurrent Urinary Tract Infection in ChildrenCompletedNCT06164600Phase 2
• A Study to Evaluate the Safety of Empliciti® (Elotuzumab) When Treating Patients With Multiple Myeloma in TaiwanCompletedNCT06163040
• CD19-targeted CAR T Cells for Relapsed and Refractory (R/R) Large B-cell LymphomaActive, not recruitingNCT06149169Phase 2
• A Safety Study of 212Pb-VMT-alpha-NET in Patients With Neuroendocrine TumorsActive, not recruitingNCT06148636Early Phase 1
• Predictive Value of Postoperative Circulating Tumor DNA Monitoring for Colorectal Cancer RecurrenceActive, not recruitingNCT06143644
• Radiomics of Treatment-naive Prostate Cancer Patients on Multiparametric MRI for Risk Stratification and Treatment Outcomes PredictionsActive, not recruitingNCT06126172Not applicable
• Laparoscopic High-Ligation Repair of Indirect Inguinal Hernias in AdultsCompletedNCT06120114Not applicable
• Practical Application of Accelerated iTBS for MDDCompletedNCT06113575Not applicable
• Real World Experience With Mogamulizumab in the Treatment of Cutaneous T-cell LymphomaCompletedNCT06113081
• Efficacy, Transfer, and Neuro-functional Basis of a Memory Training Targeting Episodic Retrieval in Older Adults.CompletedNCT06110234Not applicable
• A Study to Learn About the Study Medicine Called PF-07220060 in Combination With Fulvestrant in People With HR-positive, HER2-negative Advanced or Metastatic Breast Cancer Who Progressed After a Prior Line of TreatmentActive, not recruitingNCT06105632Phase 2
• Efficacy and Safety of VB10.16 Alone or in Combination With Atezolizumab in Patients With Advanced Cervical Cancer.WithdrawnNCT06099418Phase 2
• A Trial to Learn if Odronextamab Combined With Chemotherapy is Safe and Well-Tolerated and How Well it Works Compared to Rituximab Combined With Chemotherapy for Adult Participants With Follicular LymphomaActive, not recruitingNCT06097364Phase 3
• Study of BEBT-908 in Subjects With Advanced Hematological TumorsCompletedNCT06082596Phase 1
• Study of KITE-197 in Participants With Relapsed or Refractory Large B-cell LymphomaActive, not recruitingNCT06079164Phase 1
• Study of BEBT-908 in the Relapsed or Refractory Diffuse Large B-cell Lymphoma SubjectsCompletedNCT06074107Phase 2

← Recurrence overview